Neurosense Therapeutics News - October 20, 2026
🟢 Neurosense Therapeutics is trading 32.48% up in after-hours trading
Neurosense Therapeutics is trading at $3.10, up +32.48% in after-hours trading; no verified company-specific catalyst was identified for October 20, 2026. -...
🔴 Neurosense Therapeutics is trading 13.68% down in after-hours trading
Neurosense Therapeutics is trading at $2.02, down 13.68% in after-hours trading, with no verified company-specific catalyst identified. - On October 20, it...
🔴 Neurosense Therapeutics is trading 13.88% down with no verified company-specific catalyst identified
Neurosense Therapeutics is trading at $2.29, down 13.88%, with no verified company-specific catalyst identified for the October 20 decline. - October 19 news...
🔴 Neurosense Therapeutics is trading 10% down today — no verified company-specific catalyst
Neurosense Therapeutics is trading 9.94% lower at $2.40, with no verified company-specific catalyst for the October 20 decline. - The company’s October 19...
🟢 Neurosense Therapeutics is trading 8.4% up in pre-market
Neurosense Therapeutics is trading at $2.89, up +8.44% in pre-market, with no verified company-specific catalyst explaining the gain. - On October 19, the...
🔴 Neurosense Therapeutics is trading 6.6% down in pre-market on October 20, 2026 amid biotech weakness
Neurosense Therapeutics is trading at $2.49, down 6.57% in pre-market, with no verified company-specific catalyst identified. - The October 19 U.S. patent...